^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Endari (L-glutamine)

    i
    Other names: PGLG
    Associations

    News

    Trials
    Company:
    Emmaus
    Drug class:
    Antioxidant, Nicotinamide adenine dinucleotide modulator
    Related drugs:
    Associations

    News

    Trials
    over1year
    Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer (clinicaltrials.gov)
    P1, N=18, Active, not recruiting, Jun Gong, MD | Recruiting --> Active, not recruiting | Trial completion date: Jan 2024 --> Jul 2025
    Enrollment closed • Trial completion date • Metastases
    |
    gemcitabine • albumin-bound paclitaxel • Endari (L-glutamine)